MRVI - 3 Beaten-Down Stocks That Could Soar in the Second Half of 2022
There's a reason why the Rocky movies were so successful: Nearly everybody loves a comeback. That isn't just true in entertainment; investors like comeback stories, too.
We asked three Motley Fool contributors to pick beaten-down stocks that they think could soar in the second half of 2022. Here's why they chose Axsome Therapeutics (NASDAQ: AXSM) , Maravai Lifesciences (NASDAQ: MRVI) , and Novocure (NASDAQ: NVCR) .
Prosper Junior Bakiny (Axsome Therapeutics): Shares of small-cap biotech Axsome Therapeutics are down by more than 20% in the past year despite a recent surge. That still lags well behind the performance of the S&P 500 over the same period. But Axsome Therapeutics has been rebounding well in the past month or so for a reason -- and that could enable its stock to rise even more in the coming months.
For further details see:
3 Beaten-Down Stocks That Could Soar in the Second Half of 2022